Tissue Regenix (LSE:TRX)
Tissue Regenix is a medical devices company. Its decellularisation technology removes DNA and other cellular material from animal and human tissue, which can then be used to repair diseased or worn-out body parts.
AboutLast updated 05-06-2020, 04:28:24pm BST
These two shares could offer a mix of growth and value in current market conditions. Read More »
Edward Sheldon explains why he isn't buying into the Sirius Minerals plc (LON: SXX) story just yet. Read More »
Should you snap up these Neil Woodford favourites at big discounts? Read More »
Should you add this fast-growing stock to your portfolio or is a lower-risk established giant a better bet? Read More »
Are GlaxoSmithKline plc, Tissue Regenix Group plc and Optibiotix Health plc must-have health stocks?
Are GlaxoSmithKline plc (LON:GSK), Tissue Regenix Group plc (LON:TRX) and Optibiotix Health plc (LON:OPTI) great picks for your portfolio? Read More »
Why AstraZeneca plc, Dechra Pharmaceuticals plc And Tissue Regenix Group PLC Are A Perfect Healthcare Combination
AstraZeneca plc (LON:AZN), Dechra Pharmaceuticals plc (LON:DPH) and Tissue Regenix Group PLC (LON:TRX) are a terrific trio to buy today. Read More »
Neil Woodford will be shopping for companies like Tissue Regenix Group PLC (LON:TRX), Imperial Innovations Group plc (LON:IVO) and IP Group Plc (LON:IPO) for... Read More »